BMC Nephrology · 2012 · 30 citations · 49 references
Life SciencesGeneticsImmunologyHemodialysisImmunogeneticsMolecular ImmunologyCytokine Gene PolymorphismHumoral ImmunityInterleukin Gene VariantsViral HepatitisConfidence Intervals For Odds RatiosHepatitis B Virus GenotypeInterleukin-12 Gene VariantsInterleukin-18 Gene VariantsLogistic RegressionLogistic Regression AnalysisSurface Antigen Variation
BACKGROUND: The interleukin (IL)18 rs360719 CC genotype is associated with the development of antibodies to hepatitis B virus surface antigen (anti-HBs) in hemodialysis (HD) patients. IL18 shares biological properties with IL12 in promoting the T-hepler 1 (Th1) system. We studied whether polymorphisms in the IL12A 3` untranslated region (UTR) and IL12B 3`UTR may contribute to anti-HBs development (titre ≥ 10 IU/L) in HD patients either individually or jointly with the IL18 polymorphism. METHODS: In 518 HD patients and 240 controls the IL12A rs568408 3'UTR G > A polymorphism was genotyped by high-resolution melting curve analysis. Polymerase chain reaction restriction fragment length polymorphism was used to detect the IL12B rs3212227 3'UTR A > C and IL18 -1297 T > C rs360719 polymorphisms. The associations between the IL12A, IL12B and IL18 genotypes and the risk of impaired anti-HBs development were estimated by computing the odds ratios and their 95% confidence intervals using logistic regression analysis. RESULTS: In the logistic regression analysis, the higher frequency of rs360719 CC individually (2.9% in 207 patients without anti-HBs development vs 8.0% in 311 patients with anti-HBs development, p = 0.009) and of rs360719 CC combined with rs568408 GG (p = 0.048), rs568408 GA (p = 0.035), rs568408 GG/AA (p = 0.034) or rs3212227 AA (p = 0.046) was associated with an increased chance for the development of anti-HBs in HD patients. Patients bearing both rs568408 AA and rs360719 TT had a 10.9-fold or 8.9-fold lower chance, respectively, to develop anti-HBs compared with those carrying any other genotype (p = 0.005) or those who had both wild-type rs568408 GG and rs360719 TT (p = 0.011). Carriers of both rs3212227 CC and rs360719 TC had a 4.6-fold lower chance for anti-HBs development than carriers of any other genotype (p = 0.042). CONCLUSION: Development of anti-HBs in HD patients is associated with gene polymorphisms of interleukins involved in the Th1 system.
49
Morbidity and mortality weekly report
The American Journal of Medicine · 1997 · 4.7K citations
Cloning of a new cytokine that induces IFN-γ production by T cells
Haruki Okamura, Hiroko Tsutsui, Toshinori Komatsu et al. · Nature · 1995 · 2.6K citations
R A Seder, Ricardo T. Gazzinelli, Ali Sher et al. · Proceedings of the National Academy of Sciences · 1993 · 981 citations